Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6953777B2 · kind B2 · utility
18Cited by
14References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 9, 2000 |
| Grant date | Oct 11, 2005 |
| Priority date | — |
| Expiry date | Mar 9, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of interleukin-11 to prevent, to ameliorate, and to treat an immune-mediated disease in a mammal in need of such treatment is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.